Skip to content
Menu
Home
about AesMed
AesMed Story
AGF39
AesMed Successfully Concludes KIMES 2026 Participation
2026-04-07
AesMed is pleased to announce the successful completion of its participation in KIMES ...
Read More
Latest Posts
AesMed Successfully Concludes KIMES 2026 Participation
From Conference Posters to Credibility: How SGF57 Built Trust – Series Part 3
The Clinical Study Behind the Original SGF57 Formula – Series Part 2
SGF57: The Original Blueprint Behind AGF39 – Series Part 1
AGF39: Clinical Experience, Real-World Data, and Global Adoption- part 4
CytoMesopecia – Cytokines Mesotherapy for Alopecia- part 3
Why Korea Leads Cytokines Mesotherapy for Hair Regrowth- part 2
The Rise of Cytokines in Hair Regrowth: From Biology to Clinical Practice -Part 1
AesMed at FUE ASIA SAARC Regional Workshop 2026:
A New Beginning: AesMed Steps Forward Into 2026 With Purpose and Determination
Search for:
